Table 3 Characteristics of the study sample according to quality of life scores
Characteristic | Total (N = 226) | EQ5D | P value | EQ-VAS | P value |
|---|---|---|---|---|---|
n (%) | Median [Q1-Q3] | Median [Q1-Q3] | |||
Gender | 0.012 | 0.622 | |||
Male | 121 (53.5) | 0.73 (0.52–0.83) | 60.00 (50.00–70.00) | ||
Female | 105 (46.5) | 0.64 (0.42–0.78) | 60.00 (50.00-78.75) | ||
Age category (years) | 0.364 | 0.959 | |||
< 60 | 113 (50.0) | 0.71 (0.45–0.82) | 60.00 (50.00–70.00) | ||
≥ 60 | 113 (50.0) | 0.65 (0.49–0.79) | 60.00 (50.00–80.00) | ||
Locality | 0.188 | 0.56 | |||
Rural | 117 (51.8) | 0.69 (0.49–0.81) | 60.00 (50.00–70.00) | ||
Urban | 86 (38.1) | 0.70 (0.49–0.81) | 60.00 (50.00–80.00) | ||
Camp | 23 (10.2) | 0.60 (0.39–0.77) | 50.00 (50.00–70.00) | ||
Marital status | 0.006 | 0.077 | |||
Married | 178 (78.8) | 0.70 (0.53–0.82) | 60.00 (50.00–75.00) | ||
Single | 48 (21.2) | 0.61 (0.32–0.77) | 50.00 (46.25-70.00) | ||
Level of education | < 0.001 | 0.093 | |||
Illiterate | 19 (8.4) | 0.50 (0.28–0.73) | 60.00 (50.00–80.00) | ||
Primary | 80 (35.4) | 0.61 (0.39–0.78) | 55.00 (50.00–70.00) | ||
Secondary | 86 (38.1) | 0.70 (0.56–0.83) | 60.00 (40.00-76.25) | ||
University | 41 (18.1) | 0.79 (0.68–0.86) | 70.00 (60.00-78.75) | ||
Employment status | 0.001 | 0.043 | |||
Unemployed | 89 (39.4) | 0.64 (0.43–0.79) | 60.00 (50.00–80.00) | ||
Employed | 13 (5.8) | 0.82 (0.76–0.97) | 75.00 (52.50–90.00) | ||
Previously employed before renal failure | 124 (54.9) | 0.68 (0.51–0.79) | 60.00 (50.00–70.00) | ||
Smoking | 0.209 | 0.555 | |||
Current smoker | 52 (23) | 0.75 (0.59–0.82) | 60.00 (50.00–70.00) | ||
Previous smoker | 38 (16.8) | 0.67 (0.45–0.83) | 60.00 (50.00–80.00) | ||
Nonsmoker | 136 (60.2) | 0.65 (0.44–0.79) | 60.00 (50.00–70.00) | ||
Exercise | < 0.001 | 0.001 | |||
No | 209 (92.5) | 0.66 (0.44–0.79) | 60.00 (50.00–70.00) | ||
yes | 17 (7.5) | 0.82 (0.79-1.00) | 70.00 (70.00-89.50) | ||
Family history | 0.543 | 0.463 | |||
No | 187 (82.7) | 0.69 (0.46–0.80) | 60.00 (50.00–75.00) | ||
Yes | 39 (17.3) | 0.69 (0.54–0.82) | 60.00 (50.00–70.00) | ||
Herbal use | < 0.001 | 0.116 | |||
No | 103 (45.6) | 0.61 (0.38–0.77) | 60.00 (50.00–70.00) | ||
Yes | 123 (54.4) | 0.73 (0.56–0.83) | 60.00 (50.00–80.00) | ||
Total number of medications | 0.745 | 0.854 | |||
< 7 | 115 (50.9) | 0.67 (0.44–0.81) | 60.00 (50.00–75.00) | ||
≥ 7 | 111 (49.1) | 0.69 (0.50–0.80) | 60.00 (50.00-71.25) | ||
Number of dialysis per week | 0.659 | 0.674 | |||
< 3 | 25 (11.1) | 0.67 (0.41–0.78) | 60.00 (50.00-77.50) | ||
≥ 3 | 201 (88.9) | 0.69 (0.49–0.81) | 60.00 (50.00–70.00) | ||
Duration of renal failure | 0.219 | 0.494 | |||
< 5 | 124 (54.9) | 0.72 (0.51–0.81) | 60.00 (50.00–80.00) | ||
5-<10 | 72 (31.9) | 0.65 (0.51–0.81) | 60.00 (50.00–70.00) | ||
≥ 10 | 30 (13.3) | 0.62 (0.31–0.77) | 60.00 (40.00–70.00) | ||
Years of hemodialysis | 0.095 | 0.183 | |||
< 4 | 146 (64.6) | 0.71 (0.55–0.81) | 60.00 (50.00–80.00) | ||
≥ 4 | 80 (35.4) | 0.62 (0.42–0.79) | 60.00 (41.25-70.00) | ||
Hours of hemodialysis | 0.613 | 0.489 | |||
< 4 | 158 (69.9) | 0.67 (0.48–0.80) | 60.00 (50.00–70.00) | ||
≥ 4 | 68 (30.1) | 0.71 (0.50–0.81) | 60.00 (45.00–80.00) | ||
Number of comorbid diseases | 0.017 | 0.082 | |||
≤ 2 | 32 (14.2) | 0.73 (0.45–0.84) | 60.00 (50.00–70.00) | ||
3–4 | 97 (42.9) | 0.73 (0.57–0.82) | 60.00 (50.00–80.00) | ||
5–6 | 75 (33.2) | 0.63 (0.41–0.77) | 50.00 (45.00–70.00) | ||
> 6 | 22 (9.7) | 0.57 (0.25–0.83) | 60.00 (38.75-75.00) | ||
Received darbepoetin alfa | 0.874 | 0.341 | |||
No | 30 (13.3) | 0.69 (0.51–0.82) | 60.00 (50.00–82.00) | ||
Yes | 196 (86.7) | 0.69 (0.48–0.80) | 60.00 (50.00–70.00) | ||
Hemoglobin level | 0.039 | 0.004 | |||
< 11 | 134 (59.3) | 0.65 (0.42–0.79) | 50.0 (43.8–70.0) | ||
≥ 11 | 92 (40.7) | 0.73 (0.51–0.82) | 60.0 (50.0-78.8) |